Skip to main content

Table 5 Outcome of patients

From: Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

 

Before NICE-SUGAR

After NICE-SUGAR

P

 

n = 82,740

n = 93,765

 

ICU LOS (hours, IQR)

39.7 (21.1 to 80.1)

40.8 (21.5 to 84.3)

<0.0001

Hospital LOS (days, IQR)

9.7 (5.4 to 18.2)

9.3 (5.3 to 17.8)

0.002

Hospital outcome: home*

68% (56,673)

69% (64,547)

0.12

ICU mortality*

8% (6,480)

7% (6,728)

<0.0001

Hospital mortality*

12% (9,989)

11% (10,494)

<0.0001

  1. *percentage (number of events); ICU, intensive care unit; LOS, length of stay; NICE-SUGAR, Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation.
Back to article page

Critical Care

ISSN: 1364-8535